The Technical AnalystExchange: EURONEXT Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Tianjin Pharmaceutical Da Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.43% $2.31
America/New_York / 19 mai 2024 @ 21:57
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 289.61 mill |
| EPS: | 0.170 |
| P/E: | 13.59 |
| Earnings Date: | Apr 29, 2024 |
| SharesOutstanding: | 1 856.97 mill |
| Avg Daily Volume: | 0.146 mill |
| RATING 2024-05-17 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.80x |
| Company: PE 13.59 | sector: PE 17.08 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.57x |
| Company: PE 13.59 | industry: PE 23.71 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$2.36 (2.36%) $0.0546 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
$ 2.27 - 2.33 ( +/- 1.39%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.31 (0.43% ) |
| Volume | 0.0113 mill |
| Avg. Vol. | 0.146 mill |
| % of Avg. Vol | 7.76 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For T14.SI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
T14.SI
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.